ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene

Mol Neurobiol. 2021 Aug;58(8):3938-3952. doi: 10.1007/s12035-021-02391-0. Epub 2021 Apr 22.

Abstract

Myoclonus-dystonia (MD) is a rare childhood-onset movement disorder, with an estimated prevalence of about 2 per 1,000,.000 in Europe, characterized by myoclonic jerks in combination with focal or segmental dystonia. Pathogenic variants in the gene encoding ε-sarcoglycan (SGCE), a maternally imprinted gene, are the most frequent genetic cause of MD. To date, the exact role of ε-sarcoglycan and the pathogenic mechanisms that lead to MD are still unknown. However, there are more than 40 reported isoforms of human ε-sarcoglycan, pointing to a complex biology of this protein. Additionally, some of these are brain-specific isoforms, which may suggest an important role within the central nervous system. In the present review, we aim to provide an overview of the current state of knowledge of ε-sarcoglycan. We will focus on the genetic landscape of SGCE and the presence and plausible role of ε-sarcoglycan in the brain. Finally, we discuss the importance of the brain-specific isoforms and hypothesize that SGCE may play essential roles in normal synaptic functioning and their alteration will be strongly related to MD.

Keywords: Epsilon-sarcoglycan; Isoform; Myoclonus-dystonia; PDZ-motif; Synapse.

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Brain / metabolism
  • Brain / pathology
  • Dystonic Disorders / diagnosis
  • Dystonic Disorders / genetics*
  • Dystonic Disorders / metabolism*
  • Humans
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • Sarcoglycans / genetics*
  • Sarcoglycans / metabolism*
  • Synapses / genetics
  • Synapses / metabolism
  • Synapses / pathology

Substances

  • Protein Isoforms
  • Sarcoglycans

Supplementary concepts

  • Myoclonic dystonia